Condition: Metastatic Non-squamous Lung Cancer · Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Pulse is a randomized non-inferiority phase III clinical trial assessing a new mode of immunotherapy administration based on increased interval time between 2 infusions as maintenance treatment in Pulse arm compared with the conventional administration in Control arm. In both treatment arms, pembrolizumab alone or combined with pemetrexed is allowed as maintenance treatment. Indeed : In Pulse arm : Pembrolizumab 200 mg will be administered to patients every 6 weeks (Q6W) plus, in the absence of contra-indication pemetrexed 500 mg/m\^2 will be administered every 3 weeks (Q3W). In control arm : Pembrolizumab 200 mg will be administered to patients every 3 weeks (Q3W) or 400 mg every 6 weeks plus,in the absence of contra-indication pemetrexed 500 mg/m\^2 will be administered every 3 weeks (Q3W).
This description comes directly from the study's public registry record.
Benjamin BESSE · +33(0)1 42 11 62 61 · Benjamin.BESSE@gustaveroussy.fr
Lynda MATI · +33(0)1 42 11 37 30 · lynda.mati@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| CHU UCL Namur - Site Sainte Elisabeth | Namur, Belgium | Recruiting |
| Centre Hospitalier de Carcassonne | Carcassonne, Aude, France | Recruiting |
| Clinique Sainte Anne - Strasbourg | Strasbourg, Bas-Rhin, France | Recruiting |
| Institut de Cancérologie Strasbourg Europe (ICANS) | Strasbourg, Bas-Rhin, France | Recruiting |
| Hôpital Européen de Marseille | Marseille, Bouches-du-Rhône, France | Recruiting |
| Groupe Hospitalier La Rochelle | La Rochelle, Charente-Maritime, France | Recruiting |
| Centre Hospitalier Régional Universitaire de Brest (Hôpital Morvan) | Brest, Finistère, France | Recruiting |
| Centre Hospitalier des Pays de Morlaix | Morlaix, Finistère, France | Recruiting |
| Groupe Hospitalier de la Région de Mulhouse et Sud Alsace | Mulhouse, Haut-Rhin, France | Recruiting |
| Centre Hospitalier de Bigorre | Tarbes, Hautes-Pyrénées, France | Recruiting |
| Hôpital Foch | Suresnes, Hauts-de-Seine, France | Recruiting |
| Centre Hospitalier de Béziers | Béziers, Hérault, France | Recruiting |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05692999